Financings
Optimi investor Catcher acquires $3M in debentures

OPTI · Price
Executive Summary
- Catcher Investments Ltd. acquired $3 million worth of unsecured convertible debentures from Optimi Health Corp. in a non-brokered private placement.
- The debentures carry a 15% annual interest rate, mature in 12 to 24 months, and are convertible into common shares at a price of 15 cents per share.
- Following the acquisition, Catcher Investments holds approximately 8.52% of the undiluted common shares and 10.08% on a partially diluted basis, triggering an Early Warning Report under National Instrument 62-103.
Key Details
- Transaction Structure: Non-brokered private placement of unsecured convertible debentures.
- Investment Amount: $3,000,000 total investment.
- Quantity: 3,000 convertible debentures.
- Price per Unit: $1,000 per convertible debenture.
- Interest Rate: 15.0% per annum, calculated and payable quarterly in arrears in cash.
- Maturity: 12 months from issuance, or 24 months if extended by the acquiror.
- Conversion Price: 15 cents per common share.
- Conversion Terms:
- Principal amount convertible at the option of the acquiror upon written notice prior to the close of business on the maturity date.
- Conversion requires no additional consideration.
- Accrued and unpaid interest can be paid in cash or converted into common shares at the acquiror's election.
- If interest is converted into shares, the deemed price is the most recent closing price of the common shares on the CSE prior to the issuer receiving the conversion notice.
- At maturity, outstanding principal and accrued interest may be repaid in cash or, at the acquiror's option, through the issuance of common shares.
- Pre-Transaction Holdings: Catcher Investments owned 8,237,501 common shares (~8.52% undiluted).
- Post-Transaction Holdings:
- Common Shares: 8,237,501
- Warrants: 1,225,000
- Stock Options: 450,000
- Total Undiluted Percentage: ~8.52%
- Total Partially Diluted Percentage: ~10.08%
- Regulatory Context: Filed as an Early Warning Report in accordance with National Instrument 62-103.
More from Optimi Health Corp
Jun 29, 2026 · 09:00